Happy to share this MA before ESMO; great collab w @yysoon01 @jii_bum_lee & others
We compared TKI vs ADC in HER2m NSCLC using 1-arm studies (DL04 ❌️ included); TKI preferred - similar efficacy, less toxicity, sequencing favors TKI-first
jto.org/article/S1556-…
#lcsm
We compared TKI vs ADC in HER2m NSCLC using 1-arm studies (DL04 ❌️ included); TKI preferred - similar efficacy, less toxicity, sequencing favors TKI-first
jto.org/article/S1556-…
#lcsm